Summit Partners Public Asset Management, LLC Bio N Tech Se Transaction History
Summit Partners Public Asset Management, LLC
- $4.13 Billion
- Q4 2024
A detailed history of Summit Partners Public Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 90,000 shares of BNTX stock, worth $8.93 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
90,000Holding current value
$8.93 Million% of portfolio
0.43%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$816 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$437 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$426 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$188 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$179 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...